Our Work

Case Studies

Virtual Bioequivalence (BE) Trials

Virtual Bioequivalence (BE) Trials Challenge Conducting traditional bioequivalence (BE) trials is costly, time-intensive, and logistically complex, especially for drugs with

VIEW CASE STUDY →CLIN PHARM

Trial Design Optimisation

Trial Design Optimisation Challenge Traditional clinical trials are costly, time-consuming, and inefficient, often requiring large participant numbers and extended durations.

VIEW CASE STUDY →MECHANISTIC

Autoimmune Diseases Modeling (IgG4-Related diseases)

Autoimmune Diseases Modeling Platform Challenge Autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis involve complex immune systems and regulation.

VIEW CASE STUDY →MECHANISTIC

QSP modeling For Gene Therapy

QSP For Gene Therapy Challenge The development of new modality drugs, such as gene therapies and RNA-based treatments, presents significant

VIEW CASE STUDY →CLIN PHARM

Virtual Trial Population Simulations

Virtual Trial Population Simulations Challenge Traditional clinical trials, especially for pediatric populations, face challenges including recruitment difficulties, ethical concerns, and

VIEW CASE STUDY →MECHANISTIC

ADC Platform

ADC QSP Platform Challenge The development of antibody-drug conjugates (ADCs) is fraught with challenges, including dose-limiting toxicities, nonspecific distribution to

VIEW CASE STUDY →